Biografia de Jim Lee

Última modificação: 29 dias atrás

Jim foi Director, Immunology para a Centocor, e Chief Medical Officer da Graceway Pharmaceuticals.

Jim Lee atualmente é Group Vice President, Head Inflammation and AutoImmunity at Incyte - View - Incyte org chart

Criar um alerta
para seguir a carreira de Jim Lee.

Jim Lee possui um Bachelor of Arts pela Carleton College.

Eles também estudaram em Carleton College:

Encontre 0a Carleton College

Você precisa saber mais sobre Jim Lee? Mais resultados.

Jimmy Lee - Senior Vice President, Chief Marketing Officer - AdelFi
Jimmy Lee - Managing Director, Capital Markets - Aspen Reinsurance
Jimmy Lee - Head Asia Pacific - Bank Julius Baer
Jim Lee - Vice President, Chief Operating Officer - Bids Trading
Jimmy Lee - Chief Information Officer - Cedar Woods
Jim Lee - Director - Celsius
Jim Lee - President, Publisher and Chief Creative Officer - DC Comics
Jim Leng Lee - Non-Independent, Non-Executive Chairman of the Board - Hong Leong Asset Management
Jim Leng Lee - Director - Hong Leong Capital
Jim Leng Lee - Group Managing Director and Chief Executive Officer of Hong Leong Investment Bank Berhad - Hong Leong Financial Group
Jimmy Lee - Executive Director - Integrated Silicon Solution
Jimmy Lee - Head Asia Pacific - Julius Baer
Jimmy Lee - Chief Executive Officer and Interim Head of Private Banking of South East Asia - Julius Baer Asia
Jim Lees - Managing Director of Private Credit, New York - KKR
Jim Lee - Senior Vice President, General Counsel and Corporate Secretary - Maxar Technologies
Jim Lee - Deputy Chief Financial Officer - Pepsico
Jim Lee - Finance Director - Priory Group
Jim Lee - Vice President, Data Services - Solix Technologies
Jim Lee - Director - Tropicana Brands
Jim Lee - President, Publisher and Chief Creative Officer, DC Comics - Warner Bros. Discovery Global Brands, Franchises & Experiences
Veja todos os 20 organogramas > Fechar

Na indústria de Biotecnologia, Jim Lee possui 30.477 colegas em 2.294 empresas localizadas em 39 países. 14.198 movimentações de executivos foram registradas nos últimos 12 meses. Saiba mais sobre a indústria do Biotecnologia.